Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden.
Igarashi T, Ogura M, Itoh K, Taniwaki M, Ando K, Kuroda Y, Yamamoto K, Uike N, Tomita A, Nagai H, Kurosawa M, Mori S, Nawano S, Terauchi T, Ohashi Y, Tobinai K. Igarashi T, et al. Among authors: taniwaki m. Int J Hematol. 2017 Jan;105(1):109-110. doi: 10.1007/s12185-016-2155-3. Int J Hematol. 2017. PMID: 27896571 No abstract available.
Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach.
Ishikura S, Tobinai K, Ohtsu A, Nakamura S, Yoshino T, Oda I, Takagi T, Mera K, Kagami Y, Itoh K, Tamaki Y, Suzumiya J, Taniwaki M, Yamamoto S. Ishikura S, et al. Among authors: taniwaki m. Cancer Sci. 2005 Jun;96(6):349-52. doi: 10.1111/j.1349-7006.2005.00051.x. Cancer Sci. 2005. PMID: 15958057 Free PMC article. Clinical Trial.
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K, Watanabe T, Ogura M, Morishima Y, Ogawa Y, Ishizawa K, Minami H, Utsunomiya A, Taniwaki M, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Seriu T, Hotta T. Tobinai K, et al. Among authors: taniwaki m. J Clin Oncol. 2006 Jan 1;24(1):174-80. doi: 10.1200/JCO.2005.03.9313. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330664 Clinical Trial.
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
Mizoroki F, Hirose Y, Sano M, Fukuda H, Tobinai K, Nakata M, Taniwaki M, Kawano F, Uozumi K, Sawada K, Fukuhara S, Nasu K, Ohno Y, Toki H, Togawa A, Kikuchi M, Hotta T, Shimoyama M; Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG). Mizoroki F, et al. Among authors: taniwaki m. Int J Hematol. 2006 Jan;83(1):55-62. doi: 10.1532/IJH97.05084. Int J Hematol. 2006. PMID: 16443554 Clinical Trial.
Anti-AnWj antibody in a case with non-Hodgkin lymphoma.
Kaneko H, Oki M, Shimura K, Taniwaki M, Ohkawara Y. Kaneko H, et al. Among authors: taniwaki m. Int J Hematol. 2008 Sep;88(2):246-247. doi: 10.1007/s12185-008-0124-1. Epub 2008 Jul 4. Int J Hematol. 2008. PMID: 18600382 No abstract available.
Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.
Tobinai K, Watanabe T, Ogura M, Morishima Y, Hotta T, Ishizawa K, Itoh K, Okamoto S, Taniwaki M, Tsukamoto N, Okumura H, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Endo K. Tobinai K, et al. Among authors: taniwaki m. Cancer Sci. 2009 Jan;100(1):158-64. doi: 10.1111/j.1349-7006.2008.00999.x. Epub 2008 Oct 24. Cancer Sci. 2009. PMID: 19018755 Free article. Clinical Trial.
Renal vein lymphoma embolism in non-Hodgkin lymphoma.
Yamamoto M, Kuroda J, Kobayashi T, Uoshima N, Taniwaki M. Yamamoto M, et al. Among authors: taniwaki m. Int J Hematol. 2008 Dec;88(5):613-615. doi: 10.1007/s12185-008-0213-1. Epub 2008 Nov 28. Int J Hematol. 2008. PMID: 19039628 No abstract available.
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sakamaki H, Ishizawa KI, Taniwaki M, Fujisawa S, Morishima Y, Tobinai K, Okada M, Ando K, Usui N, Miyawaki S, Utsunomiya A, Uoshima N, Nagai T, Naoe T, Motoji T, Jinnai I, Tanimoto M, Miyazaki Y, Ohnishi K, Iida S, Okamoto S, Seriu T, Ohno R. Sakamaki H, et al. Among authors: taniwaki m. Int J Hematol. 2009 Apr;89(3):332-341. doi: 10.1007/s12185-009-0260-2. Epub 2009 Mar 5. Int J Hematol. 2009. PMID: 19263190 Clinical Trial.
725 results